121 related articles for article (PubMed ID: 1787998)
1. [Immunogenetic indicators in protracted hepatitis and their dynamics during the treatment with T-activin].
Stanevicha VA; Veksler KhM
Pediatriia; 1991; (10):44-8. PubMed ID: 1787998
[TBL] [Abstract][Full Text] [Related]
2. [Clinico-immunological evaluation of using T-activin in children with obstructive bronchitis (data of immediate and late studies)].
Eiubova AA; Budagov FG; Rzakulieva DM
Pediatriia; 1991; (1):108. PubMed ID: 2041682
[No Abstract] [Full Text] [Related]
3. [Immunotherapy using T-activin in chronic viral hepatitis B in children].
Nisevich NI; Uchaĭkin VF; Arion VIa; Cherednichenko TV; Shkliar GM
Sov Med; 1986; (12):55-9. PubMed ID: 3563706
[No Abstract] [Full Text] [Related]
4. [Immunomodulating drugs, thymalin and T-activin in the treatment of chronic liver diseases].
Iakhontova OI; Dudanova OP; Khavinson VKh
Sov Med; 1990; (6):85-8. PubMed ID: 2396134
[No Abstract] [Full Text] [Related]
5. [Interferon therapy in chronic hepatitis B and delta infection in children].
Nisevich NI; Uchaĭkin VF; Sokolova NV; Kuznetsov VP; Syr'eva TN; Cherednichenko TV; Kaganov BS; Moleva TP; Iusuf-zade AA; Guseva LN
Vestn Akad Med Nauk SSSR; 1991; (11):56-9. PubMed ID: 1767580
[No Abstract] [Full Text] [Related]
6. [The clinico-immunological effects of T-activin in the combined treatment of patients with acute suppurative pyelonephritis].
Vozianov AF; Drannik GN; Pasechnikov SP; Driianskaia VE; Petrovskaia IA; Kushko LIa; Ozvinchuk II; Potrebinskiĭ VM; Milinevskiĭ VA
Lik Sprava; 1995; (9-12):81-3. PubMed ID: 8983802
[TBL] [Abstract][Full Text] [Related]
7. [The use of immunological indices for assessing the severity of the course of periodontitis and treatment efficacy].
Bazhanov NN; Ter-Asaturov GP; Kassin VIu; Ivaniushko TP; Arion VIa; Simonova AV
Stomatologiia (Mosk); 1996; 75(1):15-8. PubMed ID: 8658566
[TBL] [Abstract][Full Text] [Related]
8. [Correction with T-activin of secondary immunodeficiency in inflammatory diseases of female internal genital organs].
Pogodin OK; Samorodinova LA; Matveeva NK; Sukhikh GT
Akush Ginekol (Mosk); 1991 Apr; (4):40-4. PubMed ID: 1862873
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic and immunomodulating effects of T-activin in frequently ailing children with acute pneumonia].
Botvin'eva VV; Botvin'ev OK; Abdullaev AR; Gumbatov LD
Pediatriia; 1989; (10):107-8. PubMed ID: 2602057
[No Abstract] [Full Text] [Related]
10. [The immunological criteria in the expediency of prescribing T-activin to patients with primary pulmonary tuberculosis].
Sakhelashvili-Haladzhun MI
Lik Sprava; 1994; (9-12):103-5. PubMed ID: 7604543
[TBL] [Abstract][Full Text] [Related]
11. [Immunotherapy for the treatment of acute appendicitis in children].
Bulanova AA; Akhanzaripov ZA
Khirurgiia (Mosk); 1994 Aug; (8):34-6. PubMed ID: 7990319
[TBL] [Abstract][Full Text] [Related]
12. [Effects of T-activin in viral myocarditis in animal experiments].
Kipshidze NN; Dzhaparidze MM; Bulusashvili RV; Khuchua AV; Zbiadadze NA
Biull Eksp Biol Med; 1988 Jun; 105(6):705-7. PubMed ID: 3260519
[TBL] [Abstract][Full Text] [Related]
13. [Clinical effectiveness of thymus preparations (T-activin, thymalin) in erysipelas infection].
Frolov VM; Peresadin NA; Pustovoĭ IuG; Gaĭdash IS; Tishchenko NA; Gavrilova LA; Pinskiĭ LL
Sov Med; 1990; (6):111-3. PubMed ID: 2144365
[No Abstract] [Full Text] [Related]
14. [Principles of immunocorrective therapy using the thymus preparation T-activin].
Arion VIa; Ivanushkin EF
Khirurgiia (Mosk); 1984 Nov; (11):44-8. PubMed ID: 6335205
[No Abstract] [Full Text] [Related]
15. [Clinical effectiveness of T-activin in the treatment of cutaneous forms of lupus erythematosus].
Skripkin IuK; Biriukov AV; Stenina MA; Skripnik AIu; Korotkiĭ NG
Vestn Dermatol Venerol; 1985 May; (5):8-11. PubMed ID: 3898631
[No Abstract] [Full Text] [Related]
16. [Effect of dimephosphon on the clinico-immunological indicators in children with chronic hepatitis].
Gorbunova IV; Shabunina EI; Maianskaia IV; Studentsova IA
Pediatriia; 1991; (10):111-2. PubMed ID: 1787992
[No Abstract] [Full Text] [Related]
17. [Immunological criteria for using thymus preparations and tuberculin therapy in the combined treatment of patients with tuberculosis].
Knoring BE; Vasil'ev AV; Sakharova IIa; Machkova NA; Ivanova LA
Probl Tuberk; 1988; (3):27-31. PubMed ID: 3260381
[No Abstract] [Full Text] [Related]
18. [Use of T-activin in patients with sarcoidosis].
Romanov VV; Khomenko IS; Ozerova LV; Gergert VIa
Probl Tuberk; 1990; (4):15-7. PubMed ID: 2395843
[TBL] [Abstract][Full Text] [Related]
19. [Immunogenetic grounds for the development of local forms of primary tuberculosis in children].
Vasil'ev AV; Dovgaliuk IF
Probl Tuberk; 1991; (10):61-2. PubMed ID: 1788235
[TBL] [Abstract][Full Text] [Related]
20. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
Balabolkin MI; Arion VIa; Petunina NA
Sov Med; 1987; (12):32-5. PubMed ID: 3502197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
